United States Federal Circuit

Affirming the district court's finding of noninfringement and remanding to determine whether the on-sale bar applies in a case relating to an anti-coagulant drug because a different production method was distinguished from the patented method and a patent is invalid if the product was offered for sale and ready for patenting prior to the filing of the application.

Appellate Information

• Published 2018/02/06

Judges

• HUGHES

Court

• United States Federal Circuit

Counsel